Acceleron Pharma - Ownership and Business Overview

Life ScienceCompany

Acceleron Pharma Ownership

Who owns Acceleron Pharma?

Acceleron Pharma is owned by Merck. It was acquired on September 30, 2021.

Acceleron Pharma Business Overview

Where is Acceleron Pharma headquartered?

Acceleron Pharma is headquartered in Cambridge, Massachusetts.

What is Acceleron Pharma’s revenue?

Acceleron Pharma disclosed revenue of 93M USD for 2020 and 74M USD for 2019.

How many employees does Acceleron Pharma have?

Acceleron Pharma has 312 employees.

What sector is Acceleron Pharma in?

Acceleron Pharma is a life science company.

When was Acceleron Pharma founded?

Acceleron Pharma was founded in 2003.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.

Acceleron Pharma

Acceleron Pharma, Inc.

128 Sidney Street,
Cambridge, Massachusetts 02139
United States,
(617) 649-9200
ww.acceleronpharma.com

Acceleron Pharma is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. Acceleron Pharma was formed in 2003 and is based in Cambridge, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.0/yr) # 1 - - - - - 1
  1

Most Recent M&A

Company Date Value Type
Andreae-Noris Zahn AG 2010-10-18 - Divestiture
Frankfurt, Germany · www.anzag.de
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) -
Total - - 1 -

By Geo

State/Country Buy Value Sell Value
Germany - - 1 -
Total - - 1 -

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.